A pharmacy that receives a Navitus audit notice is facing more than a records request. Navitus Health Solutions, the pharmacy benefit manager co-owned by SSM Health and Costco Wholesale Corporation, runs an active pharmacy audit program that can result in a recoupment demand running into the thousands of dollars per claim, network termination, or referral to a state Medicaid program integrity unit. The notice arrives with a response window stated in the pharmacy's Provider Manual, and pharmacies that miss it, or that respond without understanding what Navitus is asking for, often turn a recoverable claims dispute into a finalized debt.
Navitus's Audit Program: Desk and On-Site Reviews
Navitus administers pharmacy benefits for employer groups, health plans, and government-sponsored programs, and its compliance department conducts two forms of review: a Desk Audit, conducted by mail or electronically against submitted claims and records, and an On-Site Audit, conducted by a Navitus auditor at the pharmacy. Pharmacies are selected based on internal claims analysis, information supplied by health plans, or compliance calls. Both audit types typically require the pharmacy to produce the hard-copy prescription, the signature log, wholesaler invoices supporting the drug on hand, and any prior authorization documentation tied to the claims under review. The scope can extend across the full lookback period for claims billed to Navitus-administered plans, not only the sample identified in the notice, which is why the pharmacy's first response matters.
Transparency Positioning and Audit Exposure
Navitus markets itself as a transparency-model pharmacy benefit manager. The company is co-owned by SSM Health and Costco Wholesale Corporation, which acquired a minority equity interest in 2020, and it has built its brand on 100% rebate pass-through pricing and, starting January 2026, cost-plus pricing through Costco Pharmacy locations. That model describes how health plans compensate Navitus. It has no bearing on how Navitus audits the pharmacies in its network. A pass-through PBM still carries a contractual, and in government-plan business a regulatory, obligation to police claims accuracy, and its audit and recovery function operates independently of its pricing model. Pharmacies should not assume that transparency messaging translates into a lighter audit standard than a traditional spread-pricing PBM applies.
A missed response to a Navitus audit notice does not end the exposure. It becomes a recoupment demand that Navitus can extrapolate across the full claims sample.
Common Findings in Navitus Pharmacy Audits
Across pharmacy benefit manager audit programs, including Navitus's, the recurring focus areas are consistent: quantity and days-supply discrepancies, refill-too-soon billing, DAW (dispense as written) code accuracy, compounded and high-cost specialty claims, and prior authorization support for drugs subject to utilization management. Auditors compare what the pharmacy billed against the hard-copy prescription, wholesaler purchase records, and, for controlled substances, the state prescription drug monitoring program. A mismatch between the quantity of a drug purchased and the quantity billed is among the most common triggers for an expanded audit or fraud referral, since it suggests the pharmacy billed for product it cannot show it purchased. Pharmacies should assemble these records before the stated deadline, not after receiving a findings letter.
Responding to and Appealing a Navitus Audit
The response window stated in a Navitus audit notice is a contractual deadline, and it should be treated as firm. On receipt, the pharmacy should preserve every record tied to the claims identified, request the complete claims and findings list from Navitus in writing if the notice does not already itemize it, and avoid submitting explanations or additional documentation before counsel has reviewed the file. If Navitus issues preliminary findings, the pharmacy generally has a defined, contractually stated window to file a written appeal using Navitus's Pharmacy Audit Appeal Form, and that appeal must address each disputed claim individually rather than the audit result as a whole. The same pattern recurs across other pharmacy benefit managers, as our coverage of Humana's pharmacy audits and MedImpact's audit findings shows: a short window, a documentation-heavy request, and a PBM audit appeal that closes quickly once missed. Pharmacies handling a Navitus audit as part of a broader PBM audit defense strategy are better positioned to correct a flawed sample before it becomes a final recoupment.
Why Early Legal Counsel Is Critical
It is critical that pharmacies promptly retain healthcare defense counsel upon receiving a Navitus audit notice, documentation request, or preliminary findings letter. Early legal intervention can protect the pharmacy's rights, ensure appropriate responses to Navitus's requests, avoid inadvertent admissions, preserve relevant defenses, and allow counsel to communicate with the auditor on the pharmacy's behalf. Delaying legal representation can significantly affect the outcome of an audit and expose the pharmacy to unnecessary recoupment risk.
How Health Law Alliance Can Help
Health Law Alliance represents pharmacies nationwide in pharmacy benefit manager audits, including audits initiated by Navitus, starting with the first documentation request and continuing through appeal and, where necessary, litigation over a recoupment demand. If your pharmacy has received a Navitus audit notice or a preliminary findings letter, contact us for a free, confidential consultation.
